(XP) Xp - Ratings and Ratios
Brokerage, Funds, Cards, Loans, Insurance
XP EPS (Earnings per Share)
XP Revenue
Description: XP Xp October 31, 2025
XP Inc. (NASDAQ: XP) is a Cayman-registered fintech that operates the XP Platform, an open-architecture marketplace giving Brazilian investors access to a full suite of financial products-including brokerage securities, fixed-income, mutual, hedge and private-equity funds, derivatives, credit cards, collateralized loans, pension solutions, insurance, real-estate funds, and capital-markets services. The firm also provides brokerage and issuer services to institutional and corporate clients, manages a range of mutual and managed-portfolio funds (both active and passive), and offers inter-dealer brokerage, foreign-exchange, and commercial-banking products, complemented by a growing financial-education business delivered online and in-person.
Key metrics (FY 2023) show XP generating roughly $1.2 billion in revenue with a net profit of $350 million, supporting a client base exceeding 4 million and assets under management (AUM) of about $150 billion-making it one of Brazil’s largest independent wealth-management platforms. The company benefits from Brazil’s expanding middle class and the ongoing digital-banking shift, which has driven a 15 % year-over-year increase in active online users and a 12 % rise in transaction volume on the XP Platform.
Given the firm’s diversified product mix and strong growth in Brazil’s brokerage market (which is projected to expand at a CAGR of ~9 % through 2028), a deeper quantitative assessment could be valuable; you might explore ValueRay’s analyst tools for a data-driven view of XP’s valuation and risk profile.
XP Stock Overview
| Market Cap in USD | 9,429m |
| Sub-Industry | Investment Banking & Brokerage |
| IPO / Inception | 2019-12-11 |
XP Stock Ratings
| Growth Rating | 15.0% |
| Fundamental | 55.9% |
| Dividend Rating | 11.1% |
| Return 12m vs S&P 500 | -4.83% |
| Analyst Rating | 4.25 of 5 |
XP Dividends
| Dividend Yield 12m | 3.51% |
| Yield on Cost 5y | 1.68% |
| Annual Growth 5y | -50.38% |
| Payout Consistency | 83.2% |
| Payout Ratio | 9.3% |
XP Growth Ratios
| Growth Correlation 3m | 3% |
| Growth Correlation 12m | 69.9% |
| Growth Correlation 5y | -64.9% |
| CAGR 5y | 2.67% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.05 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.11 |
| Sharpe Ratio 12m | 0.64 |
| Alpha | -9.51 |
| Beta | 1.108 |
| Volatility | 33.97% |
| Current Volume | 5371.5k |
| Average Volume 20d | 5371.5k |
| Stop Loss | 18 (-3.4%) |
| Signal | -0.30 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (4.92b TTM) > 0 and > 6% of Revenue (6% = 577.7m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 3.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -410.2% (prev -131.2%; Δ -279.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 10.63b > Net Income 4.92b (YES >=105%, WARN >=100%) |
| Net Debt (62.07b) to EBITDA (4.49b) ratio: 13.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (535.8m) change vs 12m ago -2.84% (target <= -2.0% for YES) |
| Gross Margin 43.74% (prev 40.70%; Δ 3.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 2.87% (prev 3.19%; Δ -0.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.89 (EBITDA TTM 4.49b / Interest Expense TTM 747.3m) >= 6 (WARN >= 3) |
Altman Z'' -0.53
| (A) -0.11 = (Total Current Assets 149.95b - Total Current Liabilities 189.44b) / Total Assets 373.85b |
| (B) 0.01 = Retained Earnings (Balance) 2.55b / Total Assets 373.85b |
| (C) 0.01 = EBIT TTM 4.40b / Avg Total Assets 335.50b |
| (D) 0.05 = Book Value of Equity 17.72b / Total Liabilities 351.58b |
| Total Rating: -0.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.93
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 21.48% = 5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 3.33 = -1.25 |
| 5. Debt/Ebitda 13.81 = -2.50 |
| 6. ROIC - WACC (= 0.38)% = 0.47 |
| 7. RoE 23.24% = 1.94 |
| 8. Rev. Trend 39.49% = 2.96 |
| 9. EPS Trend -23.78% = -1.19 |
What is the price of XP shares?
Over the past week, the price has changed by +4.13%, over one month by +8.88%, over three months by +8.75% and over the past year by +9.25%.
Is Xp a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XP is around 17.66 USD . This means that XP is currently overvalued and has a potential downside of -5.26%.
Is XP a buy, sell or hold?
- Strong Buy: 5
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the XP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.1 | 23.9% |
| Analysts Target Price | 23.1 | 23.9% |
| ValueRay Target Price | 18.9 | 1.6% |
XP Fundamental Data Overview November 01, 2025
P/E Trailing = 10.5294
P/E Forward = 8.5034
P/S = 0.5609
P/B = 2.2128
Beta = 1.108
Revenue TTM = 9.63b BRL
EBIT TTM = 4.40b BRL
EBITDA TTM = 4.49b BRL
Long Term Debt = 33.29b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 74.16b BRL (from shortTermDebt, last quarter)
Debt = 74.16b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 62.07b BRL (from netDebt column, last quarter)
Enterprise Value = 48.23b BRL (50.52b + Debt 74.16b - CCE 76.45b)
Interest Coverage Ratio = 5.89 (Ebit TTM 4.40b / Interest Expense TTM 747.3m)
FCF Yield = 21.48% (FCF TTM 10.36b / Enterprise Value 48.23b)
FCF Margin = 107.6% (FCF TTM 10.36b / Revenue TTM 9.63b)
Net Margin = 51.11% (Net Income TTM 4.92b / Revenue TTM 9.63b)
Gross Margin = 43.74% ((Revenue TTM 9.63b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 20.56% (prev 22.20%)
Tobins Q-Ratio = 0.13 (Enterprise Value 48.23b / Total Assets 373.85b)
Interest Expense / Debt = 0.24% (Interest Expense 175.8m / Debt 74.16b)
Taxrate = -0.27% (negative due to tax credits) (-3.51m / 1.32b)
NOPAT = 4.41b (EBIT 4.40b * (1 - -0.27%)) [negative tax rate / tax credits]
Current Ratio = 0.79 (Total Current Assets 149.95b / Total Current Liabilities 189.44b)
Debt / Equity = 3.33 (Debt 74.16b / totalStockholderEquity, last quarter 22.26b)
Debt / EBITDA = 13.81 (Net Debt 62.07b / EBITDA 4.49b)
Debt / FCF = 5.99 (Net Debt 62.07b / FCF TTM 10.36b)
Total Stockholder Equity = 21.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.32% (Net Income 4.92b / Total Assets 373.85b)
RoE = 23.24% (Net Income TTM 4.92b / Total Stockholder Equity 21.18b)
RoCE = 8.08% (EBIT 4.40b / Capital Employed (Equity 21.18b + L.T.Debt 33.29b))
RoIC = 4.61% (NOPAT 4.41b / Invested Capital 95.75b)
WACC = 4.23% (E(50.52b)/V(124.68b) * Re(10.10%) + D(74.16b)/V(124.68b) * Rd(0.24%) * (1-Tc(-0.00)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 61.77% ; FCFE base≈10.36b ; Y1≈6.80b ; Y5≈3.11b
Fair Price DCF = 106.6 (DCF Value 45.14b / Shares Outstanding 423.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -23.78 | EPS CAGR: -54.53% | SUE: -4.0 | # QB: 0
Revenue Correlation: 39.49 | Revenue CAGR: 5.27% | SUE: -0.67 | # QB: 0
Additional Sources for XP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle